The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

BACKGROUND: Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, and the majority of NSCLC patients are diagnosed at the advanced stage. Chemotherapy is still the main treatment at present, and the overall prognosis is poor. In recent years, immunotherapy has developed rapidly....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Res Int
Egile Nagusiak: Nan, Zhang, Guoqing, Wang, Xiaoxu, Yu, Yin, Mi, Xin, He, Xue, Li, Rong, Wang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2021
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984892/
https://ncbi.nlm.nih.gov/pubmed/33791360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/1780860
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak